Found 1,258 investors
Amorim

Amorim

Portugal

Amorim is an investment holding company and is a manufacturer of cork. The company seeks to acquire other companies whose businesses can be integrated into its existing operations. The firm was founded in 1870 and is based in Mozelos, Portugal.
Strategic Acquirer
Amulet Capital Partners

Amulet Capital Partners

New York, New York, United States

Amulet Capital Partners is a middle-market private equity firm specializing in leveraged buyouts, restructurings, growth equity and other.
Private Equity Firm
a>m ventures

a>m ventures

Memphis, Tennessee, United States

a>m ventures provides startups with branding, content development, public relations strategy development, and other services.
Advertising Venture Capital

Anders Laurin

United States

Mr. Dustin Rosen is the Founder and serves as Managing Partner at Wonder Ventures. He serves as Board Member at Dack. He also serves as Investment Committee Member at USC Marshall Venture Fund. He also serves as the Board Member at Shippabo. He also is an Angel Investor. Since he began his career, he's been on every side of the business, from running and selling his own technology start-up to investing in dozens of others, as well as using this expertise to advise numerous entrepreneurs. In 2010, Dustin co-founded Pose and served as its Board Member. In 2012, Apple named it one of the best apps of the year, and at the end of 2013, Dustin guided Pose through an acquisition before beginning Wonder Ventures. Prior to Pose, Dustin worked at the Mailroom Fund, an LA-based venture capital group comprised of the William Morris Agency, Accel Partners, Venrock, and AT&T. There, Dustin focused on discovering and funding high-impact and innovative companies in the internet consumer arena. Before this, he worked at the William Morris Agency, getting his start in the infamous Mail Room. He received a B.S. in Economics from The Wharton School at The University of Pennsylvania.
Individual/Angel
Andreas & Peiffer

Andreas & Peiffer

Germany

Schüring & Andreas was a Berlin based private equity firm. The firm specialized in distress and special situations, growth financing and succession issues. It primarily invested in sectors such as electronics, machinery, telecommunication and other commercial products.
Private Equity Firm

Andres Cardenas

United States

Mr. Gilbert Lamphere serves as Angel Investor at Gilbert Lamphere. He serves as Chairman at MidRail. Mr. Lamphere has nearly 40 years of experience as a principal investor and financier in rail industry and other private equity transactions. Mr. Lamphere has headed four private equity firms and has extensive operational experience as a Chairman and/or board member for a wide range of publicly traded and private companies. Mr. Lamphere is the original financier of Precision Scheduled Railroading and the former Chairman of the Illinois Central Railway, Co-Founder of MidSouth Rail Corporation and former board member of Canadian National Railway (Chair of the Finance Committee and a member of the Compensation, Investment, and Audit committees), CSX (Operations, Finance, Compensation, and Public Affairs committees), and Florida East Coast Railway. Mr. Lamphere led teams and boards that bought, managed and revolutionized operations at Illinois Central, MidSouth, Canadian National and Florida East Coast, with alumni leading Canadian Pacific, CSX and Southern Pacific, creating gains for investors in excess of $25 billion. Mr. Lamphere has headed five private equity funds from 1981 - 2018. He served as Chairman and CEO of the Prospect Group, the first-ever publicly traded leveraged buyout fund. Mr. Lamphere was a Managing Director and member of the Board of Directors of the Fremont Group, a diversified investment company with over $9 billion of assets under management. Mr. Lamphere also co-headed the raising and management of Fremont Partners' $605 million private equity fund. Prior to his private equity firms, Mr. Lamphere was a Vice President in the M&A department at Morgan Stanley & Co. Mr. Lamphere graduated from Princeton University with an A.B. in Economics with Honors and from Harvard Business School as a Baker Scholar and recipient of the Loeb Rhoades Fellow finance prize.
Individual/Angel

Andrew Brain

United States

Mr. Baruch Glaubach serves as Managing Partner at Shevet G. Described by CNBC's Joe Terranova as one of the top oil traders on the NYMEX, he achieved success throughout all market conditions and became a mentor to other traders. Alongside his active investment in public financial markets, Mr. Glaubach has expanded into real estate, private equity, and direct business investment.
Individual/Angel

Andrew Deitchman

New York, New York, United States

Andrew Deitchman is Founder and CEO at Mother New York.
Individual/Angel

Andrew Ellenthal

Ireland

Ms. Debbie Rennick serves as General Partner at ACT Venture Capital. She is also an Angel Investor. Ms. Rennick serves as Board Observer at Meetingsbooker.com. Debbie is currently on the boards of Qumas, Capella, and Heartsine Technologies and works closely with the teams at Game, Endecco, Keelvar, and Soundwave. Previously, she has been closely involved with a number of other ACT companies including AEP (acquired by Ultra Technologies), Lifestyle Sports (acquired by Stafford Group), Nova Science (acquired by Abbott), Snapper Music & Kainos. She served as Board Member at ArraVasc. Debbie graduated from University College Dublin (UCD) with a degree in Civil Law. She also holds a Diploma in Professional Accounting and is a Fellow of the Institute of Chartered Accountants in Ireland. She served as Board Observer Visua.
Individual/Angel

Andrew MacKay

London, England, United Kingdom

Chairman at Yapp Brothers.
Individual/Angel

Andrew Murphy

United States

Mr. William McCullen serves as Chief Investment Officer at LaunchCapital. Mr. McCullen also serves as Board Member at Amastan Additive and Zagster. He is an experienced private investor and operator. Since 2009, he's invested in networking, semiconductor, clean energy, and online markets. Investments include Collaborate.com (acquired by Cisco), Incentive Targeting (acquired by Google), Daily Grommet (acquired by Rakuten), CardStar (acquired by Constant Contact), Carport (acquired by AllScripts), RunKeeper (acquired by ASICS Corporation), and many others. Previously, Mr. McCullen was an equity analyst, held senior-level technical roles at companies such as Sycamore Networks. He began his career as an engineer. Mr. McCullen received his BS and MS degrees in Electrical Engineering from Worcester Polytechnic Institute and an MBA from the MIT Sloan School of Management. He served as Board Member at Zagster and BoardOnTrack.
Individual/Angel

Andrew Pascoe

United States

Mr. Jeffery Sine cofounded and served as Partner at Raine Ventures. He is an Angel Investor. Prior to founding Raine, Jeff was Vice Chairman and Global Head of Technology, Media & Telecom Investment Banking at UBS Investment Bank. He joined UBS in April 2001 and was a board member starting in 2003. Before that time, Jeff was Global Head of Media Investment Banking at Morgan Stanley since 1991. Jeff's clients have included many of the leading global media, technology and communications companies, including Viacom, Google, Time Warner, News Corporation, Sony, Bertelsmann, Comcast, Cox Communications, Thomson, Softbank, Microsoft, AT&T, Disney and many others. Prior to Morgan Stanley, Jeff was an attorney at Sullivan & Cromwell in New York and London. Jeff is a current or past board member of The Manhattan Theatre Club, The International Radio and Television Society, The Museum of Television and Radio Media Center, The USC Annenberg School of Communication / Law Center Joint Venture and is Chair of the Board of Trustees of American University in Washington, D.C. He has also produced many plays and musicals over the past two decades on Broadway and in London's West End, and is a three-time Tony Award Winner. Jeff has a B.A. from American University and a J.D. from the University of Southern California.
Individual/Angel

Andrew Stickney

United States

Mr. Sarosh Kumana serves as an Investor at Sand Hill Angels. He is a real estate entrepreneur and angel investor based in San Francisco, with over 25 years of startup and management experience. He founded and ran a leading California government foreclosure brokerage and a mortgage brokerage company for over 15 years. He is President of Pacific Capital Management, a managing member of Junglee LLC, and also manages several other private investment vehicles. He is a member of Health Tech Capital, a limited partner in numerous VC funds, and active with Sand Hill Angels in Silicon Valley as a Board Director. Previously, he was responsible for financial product development at Citicorp and later, Controller for the Retail Banking Division at Crocker Bank in San Francisco. He has a major commitment to global sustainability. He sponsors and supports a number of educational projects in the US and around the world through the Foundation for a Sustainable Future. Locally, he is actively involved in civic, community, and political affairs, particularly involving housing and good government issues. Sarosh serves on the Ambassador Council at Global Footprint Network and on the Advisory Council of the Don Jones Center for Entrepreneurship at Tepper Business School, Carnegie Mellon University. He received a B.Com. from Sydenham College, the University of Bombay, and an MBA from Carnegie-Mellon University.
Individual/Angel

Andriy Yaroshenko

United States

Mr. Daniel Bradbury is a Co-Founder and serves as Executive Chairman at Sensulin. Mr. Daniel Bradbury is the Founder and serves as Managing Member at Biobrit. Dan currently serves on the University of California San Diego's Rady School of Management's Advisory Council and the University of Miami's Innovation Corporate Advisory Council. He serves as Board Member at Biocon. He also serves as President and Board Member at Troia Therapeutics. He served as Co-Chief Executive Officer and Chairman at DiaVacs. He served as Chairman at Freedom Meditech. He serves as an Advisor at Investor Growth Capital. He has served as a director of Geron since September 2012. He also served as a Board Member at Microdermis. He also served as a member of the boards of directors of Liquid Grids, Illumina, Inc., a manufacturer of life-science tools and integrated systems for the analysis of genetic variation and biological function; Corcept Therapeutics, a company focused on the discovery and development of drugs that regulate the effects of cortisol and BioMed Realty, a real estate investment trust focused on providing real estate to the life science industry, as well as being a member of the board of trustees of the Keck Graduate Institute. He also served on the University of California San Diego, Rady School of Management's Advisory Council, the University of Miami's Innovation Corporate Advisory Council, Investor Growth Capital Advisory Board and the BioMed Ventures Advisory Committee. Mr. Bradbury served as Chief Executive Officer of Amylin Pharmaceuticals, Inc., a biopharmaceutical company focused on diabetes and metabolic disorders, from March 2007 until its acquisition by Bristol-Myers Squibb Company in August 2012. Mr. Bradbury served as Amylin's President from June 2006 until March 2007, as Chief Operating Officer from June 2003 until June 2006, as Executive Vice President from June 2000 until June 2003 and in other positions in corporate development and marketing from 1994 until 2000. In addition, Mr. Bradbury served as a member of the board of directors of Amylin from June 2006 until August 2012. Prior to joining Amylin, he spent ten years at SmithKline Beecham Pharmaceuticals, a pharmaceutical company, holding a number of sales and marketing positions. He also serves as a director at Biomed Realty Trust. He received a Bachelor of Pharmacy from Nottingham University and a Diploma in Management Studies from Harrow and Ealing Colleges of Higher Education in the United Kingdom. He served as Chairman at Thesan Pharmaceuticals. He served as Board Member at Nuvation Bio.
Individual/Angel

Andy McIndoe

United States

Mr. Rex Golding is the Founder & serves as Managing Partner at Golding Partners. Mr. Rex Golding is an Angel Investor. He served as Senior Advisor at Arma Partners. He served as Managing Partner at Golding Capital Partners. He joined the firm in 2009. Previously, spent over 7 years as Managing Director of Mobius Venture Capital, investing in software, security and Web-based companies and achieving a number of successful M&A exits. Prior to Mobius, Rex was Co-Head of the Technology Banking Group at Morgan Stanley, where he oversaw over $20 billion of IPOs and other public financings, advised on over $150 billion of merger and acquisition transactions and personally led a number of high-profile transactions for Amazon.com, Microsoft, Netscape, Oracle, Verisign, and many other premier technology companies globally. Before Morgan Stanley, Rex was a technology entrepreneur at the 3DO Company and OnLive! Technologies. Earlier in his career Rex was an investment banker at Volpe, Welty & Co., E.F. Hutton & Co., and Salomon Brothers. Rex holds an MBA with honors from the Harvard Business School and an A.B. cum laude in Applied Mathematics from Harvard College. He also attended the California Institute of Technology and George Washington University.
Individual/Angel

Angelhere.com

United States

Mr. Chris Twiss is an Angel Investor. He served as Investment Director at The New Zealand Venture Investment Fund. Over the last 20 years he has gained extensive venture capital, private equity, angel investment, merchant banking, legal and entrepreneurial experience in London, Europe and New Zealand. Following an early career with listed agribusiness company Wrightsons in the South Island, Chris gained marketing and law degrees at Otago University before qualifying as a solicitor with Bell Gully in Wellington in 1993. From 1996, he spent seven years based in London working firstly as a commercial lawyer for Linklaters & Alliance and then as a corporate financier and venture capitalist with UK merchant bank Close Brothers PLC. After returning to New Zealand in 2003 Chris was appointed to the newly created role of Executive Director of the New Zealand Private Equity & Venture Capital Association (NZVCA). During his five years in this role Chris also served on the Boards of Incubators New Zealand and Connect New Zealand and co-authored "Fuel for your Business - An Entrepreneur's guide to Angel and Venture Capital Investment" - a New Zealand investment guide published by the NZVCA in October 2008.
Individual/Angel

Angelink

Montreal, Quebec, Canada

Management Team We look for inspired entrepreneurs with a track record of leadership and performance in this or other ventures.
Angel Group
Angel Investment Partners

Angel Investment Partners

Fort Lauderdale, Florida, United States

Nothing is publicly known about the organization other than this ScanScout investment. If you have more information, please update this
Venture Capital

Animesh Damani

United States

Dr. Kevin Hrusovsky serves as Board Member at BioIVT. He served as Board Member at Cellaria Biosciences. He also serves as President, Board Member & Chief Executive Officer at Quanterix. Dr. Hrusovsky was appointed President and CEO of Caliper Life Sciences immediately following the acquisition of Zymark Corporation by Caliper in July 2003. Before the acquisition, Dr. Hrusovsky served as President and CEO for Zymark starting in late 1996. Dr. Hrusovsky successfully transformed Zymark from a custom robotics company into a formidable Life Sciences "Tools" company through acquisitions, R&D investment and recruitment of top industry talent. Before joining Zymark, Dr. Hrusovsky was president of the Pharmaceutical Division at FMC and ran the Teflon and other specialty businesses at Dupont. His entire career has been associated with managing transformative innovation into sustainably profitable enterprises. He is on the Global Research Council for Children's Hospital, Boston and is a member of the Advisory Committee for the Center for Biomedical Engineering at Brown University. He received an Honorary Doctorate from Framingham State University for contributions to life sciences. Dr. Hrusovsky holds a BSME from Ohio State and M.B.A. from Ohio University. Dr. Hrusovsky served as a Board Member at SynapDx. Previously, Hrusovsky served as president of life sciences and technology at PerkinElmer. He also holds an MBA (Master of Business Administration) degree from Ohio State University and a degree from Harvard University. He also serves as Chairman at 908 Devices.
Individual/Angel
Another Challenge Ventures

Another Challenge Ventures

Sydney, New South Wales, Australia

Another Challenge Ventures is a boutique investment group that focuses on cybersecurity opportunities.
Cyber Security Financial Services Venture Capital Venture Capital
Showing 201 to 220 of 1,258 results